Click here to close now.




















Welcome!

API Journal Authors: Pat Romanski, Elizabeth White, Carmen Gonzalez, Liz McMillan, AppDynamics Blog

News Feed Item

Global Proteomics Industry

NEW YORK, Dec. 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Proteomics Industry

http://www.reportlinker.com/p092466/Global-Proteomics-Industry.html#utm_...

 

This report analyzes the worldwide markets for Proteomics in US$ Million by the following Product Segments: Expression Proteomics, Functional Proteomics, and Structural Proteomics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period of 2010 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 111 companies including many key and niche players such as ActivX Biosciences, Inc., Adnexus Therapeutics, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Daltonics, Inc., Caprion Proteomics, Inc., Digilab Genomic Solutions, Inc., Dionex Corporation, GE Healthcare, Geneva Bioinformatics S.A., Hybrigenics SA, Life Technologies Corporation, Millipore Corp., PerkinElmer, Inc., Caliper Life Sciences, Shimadzu Biotech, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Waters Corp., Xencor Inc., and Zyomyx, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

 

 

 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Expression Proteomics I-3

Functional Proteomics I-3

Structural Proteomics I-4

 

 

II. EXECUTIVE SUMMARY

 

1. GLOBAL MARKET OVERVIEW II-1

Proteomics - The Current Spotlight II-1

Market Drivers II-1

Transition from Genomics to Proteomics II-1

Industrialization of Proteomics Research II-2

International Initiatives Light-up Proteomics Market II-2

Factors Limiting Market Growth II-2

Economic Recession Impact on the Life Sciences Industry in

Retrospect II-2

Biotechnology Sector - Affected by Collapse of Capital Market II-3

Tough Times for Market Participants II-3

Proteomics Technologies: Growing in Significance II-4

Transformation of Drug Discovery through Proteomics and Genomics II-5

Proteomics: A Critical Drug Discovery Tool II-5

China All Set To Play a Major Role in the Proteomics Industry II-6

Global Proteomics Sample Preparation Market - On a Growth Curve II-7

Challenges Facing Proteomics Sample Preparation Market II-7

Challenges Facing Proteomics Industry II-7

Protein Chemistry and its Complexities II-7

Integration of Data & Equipment II-7

Data Validation - A Burning Issue II-8

Standardization & Consistency - A Prime Concern II-8

Incomplete and Disorganized Data II-8

 

2. INDUSTRY COMPETITION II-9

Industry Participants II-9

Proteomics Market Worldwide: Competitive Landscape II-9

Proteomics Supplier Market II-9

Tool Providers: Leading the Proteomics Market II-10

Applied Biosystems-Invitrogenc Corporation Merger - A Key

Development II-10

Challenges Ahead II-11

Designing a Novel Business Model II-11

Role of Contract Research Organizations - All Set to Increase

in Proteomics II-11

 

3. PRODUCT AND TECHNOLOGY OVERVIEW II-12

Proteins, Proteome and Proteomics!!! - What are They? II-12

Proteomics - An Introduction II-12

Genesis of Proteomics II-13

Tales From Times Gone By II-13

Components of Proteomics II-13

Expression Proteomics II-13

Functional Proteomics II-14

Cell-map Proteomics II-14

Structural Proteomics II-14

Technologies and Proteomics II-14

Proteomics and Genomics II-15

Proteomics and Genomics: A Comparison II-15

Protein Production Pathway: From Gene Expression to

Functional Protein with Controls II-15

From Genomics to Proteomics II-16

Functional Genomics and Proteomics II-16

Push From Genomic Information II-17

An Insight into Proteomics Data Type and their

Characteristics / Features II-17

Standard Proteomics Approach II-17

Sample Preparation - Step I II-18

Protein Separation - Step II II-18

Protein Visualization II-18

Protein Expression Analysis-Step III II-18

Protein Identification - Step IV II-19

Data Storage and Processing - Step V II-19

 

4. OVERVIEW OF PROTEOMICS TECHNOLOGIES II-20

A Snapshot of Various Proteomics Tools II-20

An Insight into Various Proteomics Technologies and their

Application Areas II-20

Protein Separation II-20

2-Dimensional Gel Electrophoresis (2DGE) II-20

Protein Characterization II-22

Analysis of Protein Through Mass Spectrometry II-22

MS and Proteins II-22

Applications of MS II-23

Problems Associated with MS II-24

Types of Analyzers or Filters II-24

Y2H, Yeast 2-Hybrid System II-25

Protein Microarrays II-26

Chip Technology II-26

Microfluidic Applications II-27

Role of Bioinformatics in Proteomics II-27

Bioinformatics Applications and Tools in Proteomics II-27

Emerging Proteomics Technologies II-29

MudPIT II-29

ICAT II-29

Phage Display Technique II-30

Advanced Proteomics Technologies: Structural Analysis Tools II-30

X-ray Crystallography II-30

Nuclear Magnetic Resonance (NMR) II-30

In silico Modelling II-31

Physicochemical Factors Constraining Metabolic Functions II-31

 

5. END-USE APPLICATION AREAS II-32

Proteomics in Drug and Diagnostic Discovery II-33

Proteomics and Drug Discovery II-33

Protein Microarrays: A New Tool for the Development of

Pharmaceuticals II-34

Proteomic Approaches Gain Prominence in Cancer Drug Discovery II-34

Advancements in Proteomics Bring Biomarkers into Limelight II-35

 

6. NEW PRODUCT SOLUTIONS/ DEVELOPMENTS II-36

Applied Biomics Introduces Global Protein Post- Translational

Modification II-36

AB SCIEX Launches New Column Chips II-36

Applied Biomics Introduces New Mass Spectrometry Service II-37

Norton Scientific Introduces Novel Specialist Applications

Development Laboratory Service II-37

Gentel Biosciences Introduces APiXTM Disease Profiling Kit II-38

Integromics Introduces OmicsHub Proteomics 2.0 II-38

Bruker Introduces amaZon Speed Ion Trap Mass Spectrometers II-39

Applied Biomics Introduces iTRAQ Service for Proteomics Research II-39

Norton Scientifc Company Introduces New Lab Support Service

for Rapid RNA/DNA and Protein Measurement II-39

Bruker Launches MALDI BiotargetTM II-40

Thermo Fisher Launches UHLPC System II-40

Kinexus Introduces Human Gene Online TranscriptoNET KnowledgeBase II-41

Bruker Launches PRIME Integrated Proteomics Solution II-42

Applied Biosystems Launches LS*LIMS Laboratory Automation

Technology for Proteomics and Genomics II-42

Kinexus Bioinformatics Introduces Online KiNET-AM Proteomics

DataBase II-42

Bruker Rolls Out CaptiveSpray Electrospray Ion Source for

Proteomics Applications II-43

Thermo Fisher Launches New Capabilities for Performing

Proteomics Workflows II-43

National Cancer Institute Introduces Clinical Proteomic Tumor

Analysis Consortium for Cancer Studies II-44

KinaSorbTM' - New Kit for Kinase Enrichment II-45

 

7. PRODUCT INTRODUCTIONS/INNOVATIONS IN RECENT PAST - A

PERSPECTIVE BUILDER II-46

Gentel Biosciences Unveils Gentel Proteomics Multi-SystemTM II-46

caprotec bioanalytics Introduces Innovative caproKits II-46

Gentel Biosciences Introduces SilverQuant® Simian Pathogen

Array for Health Monitoring of Laboratory Animals II-46

Gentel Biosciences Introduces SilverQuant® Human Tumor

Profiling Kits II-46

Gentel Biosciences Introduces SilverQuant® Disease Profiling Kit II-47

Gentel Biosciences Introduces SilverQuant® View Detection Kits II-47

Gentel Biosciences Launches Proteomics Multi-System II-47

New England Peptide Introduces NEPTune™ Range of Proteomics

Reagents II-48

Applied Biomics Introduces NanoLC-MS/MS Service II-48

Life Technologies Introduces Magic Sample Processor for

Epigenetics, Proteomics Sample Preparation II-49

Integromics Introduces SeqSolve™ NGS Bioinformatics Analysis

Software II-50

Thermo Fisher Scientific Unveils Software Suite for Enhanced

Workflows in Proteomics II-50

Proxeon Introduces EASY-nLC II System for Improved

Productivity in Proteomics (Denmark) II-51

Gentel Biosciences Launches Proteomics Multi-System II-51

Arrayit Discovers New Proteomic Biomarkers II-52

Kinexus Bioinformatics Launches Peptide Development Facility II-52

Bruker Daltonics Unveils ultrafleXtreme™ MALDI-TOF/TOF Mass

Spectrometer II-52

Agilent Technologies Rolls Out HPLC-Chip II-53

Applied Biosystems and MDS Introduce AB SCIEX TOF/TOF™ 5800

System II-53

Applied Biomics Extends Proteomics Service Offerings II-54

AnaSpec Introduces Keratin Antibodies II-54

caprotec bioanalytics Unveils cAMP caproKit and SAH caproKit II-54

Huzhou Sai'erdi Biopharmaceutical Introduces Proteomic

Fingerprint Technology Test Kit II-54

 

8. RECENT INDUSTRY ACTIVITY II-55

Life Technologies Enters into Partnership with Sino Biological II-55

Proteome Sciences Signs Agreement with CHDI Foundation II-55

Waters Corp. Inks Agreement with Nonlinear Dynamics II-56

BioFocus Enters into Alliance with Activiomics II-56

Great Point Partners Divests Caprion Proteomics II-56

Glaxo Smith Kline Takes Over Cellzome II-57

Emerald BioSystems Changes Name to Emerald Bio II-57

Bruker Unveils Novel Nano-Advance UHPLC System II-57

Evotec Takes Over Kinaxo Biotechnologies II-58

Kinaxo Biotechnologies and AstraZeneca Sign Agreement II-58

Gentel Biosciences Takes Over Eppendorf's SilverQuant Trademark II-58

Thermo Fisher Takes Over Fermentas International II-58

KINAXO to Collaborate with Takeda II-59

Dualsystems and Bulldog Bio Signs Exclusive Marketing Agreement II-59

Novartis Enters into Agreement with SomaLogic II-59

Sage-N Inks Exclusive Pact With the U.S. Army II-59

Proteome Sciences Inks Agreement with Moffitt Cancer Center II-60

Gentel Biosciences Enters into Agreement with Oregon Health &

Science University II-60

Evotec OAI Forms Joint Venture with MeITec to Collaborate on

Drug Discovery Services II-60

 

9. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER II-61

MicroBioChips Merges with Biosystems II-61

Caprion Proteomics Acquires Biomarket Unit from PPD Biomarker

Discovery Sciences II-61

ICON Enters into Strategic Alliance with Proteome Sciences II-61

Gentel Enters into Partnership with RayBiotech for

SilverQuant® Chromogenic Detection Platform II-61

Trans-Hit Biomarkers Enters into Alliance with Caprion to

Deliver Proteome-Hit Services II-62

Proteoprep Enters into License Agreement with Sigma-Aldrich II-62

Activiomics Signs Technology Agreement with UCB for Proteomics

Platform(UK/Belgium) II-63

Expression Pathology Enters into Service Partnership with

Flagship for Tissue Proteomics Development II-63

National Cancer Institute Enters into MoU with AACC in

Proteomics Sector II-63

MGL Americas and ProFACT Proteomics Team Up for Biomarker

Discovery II-64

Thermo Fisher Scientific and Luxembourg Clinical Proteomics

Unit Form Collaboration (Luxembourg) II-64

Covance Unveils Discovery and Translational Services Division II-65

Thermo Fisher Scientific Takes Over Proxeon II-65

TriLink BioTechnologies and Nacalai USA Sign Distribution

Agreement II-65

Cell Biosciences Takes Over Alpha Innotech II-65

Eurogentec to Take Over Ana Spec II-66

Merck Takes Over Bangalore Genei II-66

Cell Biosciences Takes Over Protein Forest II-66

Microsoft to Acquire Rosetta Bio Software Assets II-67

CCMB and Bio-Rad India Sign MoU II-67

SAIC-Frederick and Sensor Technologies Ink Collaboration

Agreement II-67

NuSep Signs Purchase Agreement with BioInquire II-68

Intrinsic Bioprobes Bags Contract from NCI II-68

HORIBA Jobin Yvon Acquires GenOptics II-68

Gentel Biosciences Partners with Eprogen II-68

Bruker Daltonics Installs High-Field 15 Tesla and 12 Tesla

FTMS Systems at LUMC II-69

Genedata Extends Collaboration with Roche II-69

AliX Merges with Novalyst Discovery to form NovAliX II-70

BioPike and AnaSpec Sign Agreement II-70

Sigma-Aldrich Purchases Electrophoresis Business of NextGen

Sciences II-70

Fujifilm Purchases Additional Stake in Perseus Proteomics II-71

Sigma-Aldrich Buys Seppro® Depletion Technology and 700

Antibodies II-71

Oxford Gene Technology Purchases Sense Proteomic II-72

Center for Cancer Research Acquires Waters® UPLC/MS Systems II-72

 

10. FOCUS ON SELECT KEY PLAYERS II-74

ActivX Biosciences, Inc. (US) II-74

Adnexus Therapeutics (US) II-74

Agilent Technologies, Inc. (US) II-74

Bio-Rad Laboratories, Inc. II-74

Bruker Daltonics, Inc. (US) II-75

Caprion Proteomics, Inc. (Canada) II-75

Digilab Genomic Solutions, Inc. (US) II-76

Dionex Corporation (US) II-76

GE Healthcare (United Kingdom) II-76

Geneva Bioinformatics S.A. (Switzerland) II-76

Hybrigenics SA (France) II-76

Life Technologies Corporation (US) II-77

Millipore Corp. (US) II-77

PerkinElmer, Inc. (US) II-78

Caliper Life Sciences (US) II-78

Shimadzu Biotech (Japan) II-78

Sigma-Aldrich Corporation (US) II-78

Thermo Fisher Scientific (US) II-79

Waters Corp. (US) II-79

Xencor Inc. (US) II-80

Zyomyx, Inc. (US) II-80

 

11. GLOBAL MARKET PERSPECTIVE II-81

Table 1: World Recent Past, Current & Future Analysis for

Proteomics by Geographic Region - US, Canada, Japan, Europe

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-81

 

Table 2: World Historic Review for Proteomics by Geographic

Region - US, Canada, Japan, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-82

 

Table 3: World 15-Year Perspective for Proteomics by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe and Rest of World Markets for Years

2004, 2011 and 2018 (includes corresponding Graph/Chart) II-83

 

Table 4: World Recent Past, Current & Future Analysis for

Proteomics by Segment - Expression Proteomics, Functional

Proteomics and Structural Proteomics Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2010 through 2018 (includes corresponding Graph/Chart) II-84

 

Table 5: World Historic Review for Proteomics by Segment -

Expression Proteomics, Functional Proteomics and Structural

Proteomics Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-85

 

Table 6: World 15-Year Perspective for Proteomics by Segment -

Percentage Breakdown of Dollar Sales for Expression

Proteomics, Functional Proteomics and Structural Proteomics

Markets for Years 2004, 2011 and 2018 (includes corresponding

Graph/Chart) II-86

 

12. GLOSSARY OF TERMS II-87

1-D, 2-D, 3-D II-87

Atmospheric Pressure Ionisation II-87

Electrophoresis II-87

Functional Genomics II-87

High-Throughput II-87

Liquid Chromatography (LC) II-87

Mass Spectrometry (MS) II-87

Matrix-Assisted Laser Desorption Ionisation (MALDI) II-87

Nuclear Magnetic Resonance II-88

X-ray Diffraction II-88

Yeast Two-Hybrid System II-88

2D-PAGE (Two-dimensional PolyAcrylamide Gel Electrophoresis) II-88

TOF (Time of Flight) II-88

Quadrupole II-88

Q-TOF (Quadrupole Time of Flight) II-88

ESI (Electrospray Ionisation) II-88

 

 

III. MARKET

 

1. THE UNITED STATES III-1

A.Market Analysis III-1

Outlook III-1

Proteomics Sample Preparation Market III-1

New Product Developments III-1

Strategic Corporate Developments III-6

Select Key Players III-9

B.Market Analytics III-14

Table 7: The US Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-14

 

Table 8: The US Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-15

 

2. CANADA III-16

A.Market Analysis III-16

Outlook III-16

New Product Developments III-16

Strategic Corporate Development III-18

Caprion Proteomics, Inc. - A Key Player III-18

B.Market Analytics III-19

Table 9: Canadian Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-19

 

Table 10: Canadian Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-20

 

3. JAPAN III-21

A.Market Analysis III-21

Shimadzu Biotech - A Key Player III-21

B.Market Analytics III-21

Table 11: Japanese Recent Past, Current & Future Analysis

for Proteomics Market Analyzed with Annual Sales Figures in

US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-21

 

Table 12: Japanese Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2004 through 2009 (includes corresponding Graph/Chart) III-22

 

4. EUROPE III-23

A.Market Analysis III-23

Outlook III-23

Proteomics Research in Europe - An Overview III-23

Table 13: European Proteomics Market (2011): Percentage

Breakdown of Deployment of Proteomics Technologies in

End-Use Segments - Research and Academic Institutions,

Pharmaceutical Companies and Clinical Laboratories

(includes corresponding Graph/Chart) III-24

Protein Identification Market III-24

Protein Separation Market III-24

Market Challenges III-25

Gaining Edge in the Proteomics Industry - Player Strategies III-25

European 2DE Market - Benefiting from Recession III-26

Review of Select Markets III-26

Germany III-26

The United Kingdom III-26

New Product Developments III-27

Strategic Corporate Developments III-28

Select Key Players III-30

B.Market Analytics III-31

Table 14: European Recent Past, Current & Future Analysis

for Proteomics by Geographic Region - France, Germany, UK

and Rest of Europe Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2010 through

2018 (includes corresponding Graph/Chart) III-31

 

Table 15: European Historic Review for Proteomics by

Geographic Region - France, Germany, UK and Rest of Europe

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-32

 

Table 16: European 15-Year Perspective for Proteomics by

Geographic Region - Percentage Breakdown of Dollar Sales for

France, Germany, UK andRest of Europe Markets for Years

2004, 2011 and 2018 (includes corresponding Graph/Chart) III-33

 

5. REST OF WORLD III-34

A.Market Analysis III-34

Outlook III-34

Australia III-34

India III-34

Indian Scientific Research towards Functional Genomics and

Proteomics III-34

B.Market Analytics III-35

Table 17: Rest of World Recent Past, Current & Future

Analysis for Proteomics Market Analyzed with Annual Sales

Figures in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-35

 

Table 18: Rest of World Historic Review for Proteomics

Market Analyzed with Annual Sales Figures in US$ Million for

Years 2004 through 2009 (includes corresponding Graph/Chart) III-36

 

 

IV. COMPETITIVE LANDSCAPE

 

Total Companies Profiled: 111 (including Divisions/Subsidiaries - 128)

 

The United States (82)

Canada (4)

Japan (3)

Europe (39)

- France (3)

- Germany (10)

- The United Kingdom (13)

- Spain (1)

- Rest of Europe (12)

 

 

 

To order this report:

Drug_Discovery_and_Development Industry: Global Proteomics Industry

 

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

 

 

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
For IoT to grow as quickly as analyst firms’ project, a lot is going to fall on developers to quickly bring applications to market. But the lack of a standard development platform threatens to slow growth and make application development more time consuming and costly, much like we’ve seen in the mobile space. In his session at @ThingsExpo, Mike Weiner, Product Manager of the Omega DevCloud with KORE Telematics Inc., discussed the evolving requirements for developers as IoT matures and conducted a live demonstration of how quickly application development can happen when the need to comply wit...
Explosive growth in connected devices. Enormous amounts of data for collection and analysis. Critical use of data for split-second decision making and actionable information. All three are factors in making the Internet of Things a reality. Yet, any one factor would have an IT organization pondering its infrastructure strategy. How should your organization enhance its IT framework to enable an Internet of Things implementation? In his session at @ThingsExpo, James Kirkland, Red Hat's Chief Architect for the Internet of Things and Intelligent Systems, described how to revolutionize your archit...
It is one thing to build single industrial IoT applications, but what will it take to build the Smart Cities and truly society-changing applications of the future? The technology won’t be the problem, it will be the number of parties that need to work together and be aligned in their motivation to succeed. In his session at @ThingsExpo, Jason Mondanaro, Director, Product Management at Metanga, discussed how you can plan to cooperate, partner, and form lasting all-star teams to change the world and it starts with business models and monetization strategies.
The Internet of Everything (IoE) brings together people, process, data and things to make networked connections more relevant and valuable than ever before – transforming information into knowledge and knowledge into wisdom. IoE creates new capabilities, richer experiences, and unprecedented opportunities to improve business and government operations, decision making and mission support capabilities.
The Internet of Things is not only adding billions of sensors and billions of terabytes to the Internet. It is also forcing a fundamental change in the way we envision Information Technology. For the first time, more data is being created by devices at the edge of the Internet rather than from centralized systems. What does this mean for today's IT professional? In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists addressed this very serious issue of profound change in the industry.
Discussions about cloud computing are evolving into discussions about enterprise IT in general. As enterprises increasingly migrate toward their own unique clouds, new issues such as the use of containers and microservices emerge to keep things interesting. In this Power Panel at 16th Cloud Expo, moderated by Conference Chair Roger Strukhoff, panelists addressed the state of cloud computing today, and what enterprise IT professionals need to know about how the latest topics and trends affect their organization.
SYS-CON Events announced today that HPM Networks will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. For 20 years, HPM Networks has been integrating technology solutions that solve complex business challenges. HPM Networks has designed solutions for both SMB and enterprise customers throughout the San Francisco Bay Area.
Converging digital disruptions is creating a major sea change - Cisco calls this the Internet of Everything (IoE). IoE is the network connection of People, Process, Data and Things, fueled by Cloud, Mobile, Social, Analytics and Security, and it represents a $19Trillion value-at-stake over the next 10 years. In her keynote at @ThingsExpo, Manjula Talreja, VP of Cisco Consulting Services, discussed IoE and the enormous opportunities it provides to public and private firms alike. She will share what businesses must do to thrive in the IoE economy, citing examples from several industry sectors.
Growth hacking is common for startups to make unheard-of progress in building their business. Career Hacks can help Geek Girls and those who support them (yes, that's you too, Dad!) to excel in this typically male-dominated world. Get ready to learn the facts: Is there a bias against women in the tech / developer communities? Why are women 50% of the workforce, but hold only 24% of the STEM or IT positions? Some beginnings of what to do about it! In her Opening Keynote at 16th Cloud Expo, Sandy Carter, IBM General Manager Cloud Ecosystem and Developers, and a Social Business Evangelist, d...
There will be 150 billion connected devices by 2020. New digital businesses have already disrupted value chains across every industry. APIs are at the center of the digital business. You need to understand what assets you have that can be exposed digitally, what their digital value chain is, and how to create an effective business model around that value chain to compete in this economy. No enterprise can be complacent and not engage in the digital economy. Learn how to be the disruptor and not the disruptee.
Akana has released Envision, an enhanced API analytics platform that helps enterprises mine critical insights across their digital eco-systems, understand their customers and partners and offer value-added personalized services. “In today’s digital economy, data-driven insights are proving to be a key differentiator for businesses. Understanding the data that is being tunneled through their APIs and how it can be used to optimize their business and operations is of paramount importance,” said Alistair Farquharson, CTO of Akana.
Business as usual for IT is evolving into a "Make or Buy" decision on a service-by-service conversation with input from the LOBs. How does your organization move forward with cloud? In his general session at 16th Cloud Expo, Paul Maravei, Regional Sales Manager, Hybrid Cloud and Managed Services at Cisco, discusses how Cisco and its partners offer a market-leading portfolio and ecosystem of cloud infrastructure and application services that allow you to uniquely and securely combine cloud business applications and services across multiple cloud delivery models.
The enterprise market will drive IoT device adoption over the next five years. In his session at @ThingsExpo, John Greenough, an analyst at BI Intelligence, division of Business Insider, analyzed how companies will adopt IoT products and the associated cost of adopting those products. John Greenough is the lead analyst covering the Internet of Things for BI Intelligence- Business Insider’s paid research service. Numerous IoT companies have cited his analysis of the IoT. Prior to joining BI Intelligence, he worked analyzing bank technology for Corporate Insight and The Clearing House Payment...
In his keynote at 16th Cloud Expo, Rodney Rogers, CEO of Virtustream, discussed the evolution of the company from inception to its recent acquisition by EMC – including personal insights, lessons learned (and some WTF moments) along the way. Learn how Virtustream’s unique approach of combining the economics and elasticity of the consumer cloud model with proper performance, application automation and security into a platform became a breakout success with enterprise customers and a natural fit for the EMC Federation.
"Optimal Design is a technology integration and product development firm that specializes in connecting devices to the cloud," stated Joe Wascow, Co-Founder & CMO of Optimal Design, in this SYS-CON.tv interview at @ThingsExpo, held June 9-11, 2015, at the Javits Center in New York City.
SYS-CON Events announced today that CommVault has been named “Bronze Sponsor” of SYS-CON's 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. A singular vision – a belief in a better way to address current and future data management needs – guides CommVault in the development of Singular Information Management® solutions for high-performance data protection, universal availability and simplified management of data on complex storage networks. CommVault's exclusive single-platform architecture gives companies unp...
Electric Cloud and Arynga have announced a product integration partnership that will bring Continuous Delivery solutions to the automotive Internet-of-Things (IoT) market. The joint solution will help automotive manufacturers, OEMs and system integrators adopt DevOps automation and Continuous Delivery practices that reduce software build and release cycle times within the complex and specific parameters of embedded and IoT software systems.
"ciqada is a combined platform of hardware modules and server products that lets people take their existing devices or new devices and lets them be accessible over the Internet for their users," noted Geoff Engelstein of ciqada, a division of Mars International, in this SYS-CON.tv interview at @ThingsExpo, held June 9-11, 2015, at the Javits Center in New York City.
Internet of Things is moving from being a hype to a reality. Experts estimate that internet connected cars will grow to 152 million, while over 100 million internet connected wireless light bulbs and lamps will be operational by 2020. These and many other intriguing statistics highlight the importance of Internet powered devices and how market penetration is going to multiply many times over in the next few years.
SYS-CON Events announced today that Dyn, the worldwide leader in Internet Performance, will exhibit at SYS-CON's 17th International Cloud Expo®, which will take place on November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Dyn is a cloud-based Internet Performance company. Dyn helps companies monitor, control, and optimize online infrastructure for an exceptional end-user experience. Through a world-class network and unrivaled, objective intelligence into Internet conditions, Dyn ensures traffic gets delivered faster, safer, and more reliably than ever.